Insider Transactions in Q2 2022 at Fibrogen Inc (FGEN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
655
-0.71%
|
$7,205
$11.42 P/Share
|
|
Jun 16
2022
|
James A Schoeneck |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+43.52%
|
-
|
|
Jun 16
2022
|
Gerald Lema |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+43.52%
|
-
|
|
Jun 16
2022
|
Suzanne Blaug |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+34.6%
|
-
|
|
Jun 16
2022
|
Aoife Brennan |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+39.28%
|
-
|
|
Jun 16
2022
|
Benjamin Cravatt |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+39.28%
|
-
|
|
Jun 16
2022
|
Jeffrey L Edwards |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+31.97%
|
-
|
|
Jun 16
2022
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+31.97%
|
-
|
|
Jun 16
2022
|
Maykin Ho |
BUY
Grant, award, or other acquisition
|
Direct |
15,777
+33.21%
|
-
|
|
Jun 06
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-0.4%
|
$3,240
$9.5 P/Share
|
|
Jun 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-0.58%
|
$15,948
$9.5 P/Share
|
|
Jun 06
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,850
-0.75%
|
$16,650
$9.5 P/Share
|
|
Jun 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,141
-0.76%
|
$10,269
$9.61 P/Share
|
|
Apr 07
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-0.43%
|
$15,732
$12.73 P/Share
|